Stock AnalizAmerican Healthcare REIT, Inc. AHR
Real Estate Investment Trusts · IPO 2024 · data as of November 13, 2026
American Healthcare REIT, Inc. (AHR) is a real estate company listed in the US with a market value of about $13.4B. In the twelve months to September 30, 2026 it had revenue of $2.7B and net income of $96M, a net margin of 3.6%.
Its overall Stock Analiz score is 1.8 out of 5 (weak). The strongest part is shareholder returns (3/5); the weakest is value (0/5).
Key numbers: a P/E of 117.9, 5-year revenue growth of 16% a year, a 5-year average ROIC of 8%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 42% below the current price.
Score: 1.8 / 5
Checks passed
- 3-year revenue growth above 10% a year
- Profit margin improving
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
- Pays a dividend
- Dividend 3 years in a row
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.3B | $2.1B | $1.9B | $1.4B | $1.1B | $1.1B | $1.1B | $84M | $33M | $3M |
| Net income | $96M | $70M | -$38M | -$71M | -$81M | -$48M | $2M | -$5M | -$8M | $541000 | -$5M |
| Free cash flow | -$2.0B | -$590M | $116M | $53M | $140M | — | $211M | $111M | $11M | $11M | -$4M |
| EPS (diluted) | $0.49 | $0.42 | $-0.29 | $-1.08 | $-1.24 | $-0.95 | $0.05 | $-0.12 | $-0.60 | $0.08 | $-7.00 |
| Net margin | 3.6% | 3.1% | -1.8% | -3.8% | -5.8% | -4.2% | 0.2% | -0.4% | -9.9% | 1.6% | -173.4% |
| ROIC | — | 7.4% | 8.4% | 8.6% | 8.2% | 5.9% | 9.1% | 27.9% | -0.1% | 0.9% | -3.9% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 16 analysts is $66.31, 15% above the current price; targets range from $55.00 to $74.00; the consensus rating is “Strong buy”; expected EPS is $0.65 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is American Healthcare REIT’s P/E ratio?
About 117.9, based on the last twelve months of diluted earnings per share (forward P/E about 63.1).
Is American Healthcare REIT stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 42% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does American Healthcare REIT pay a dividend?
Yes. The dividend yield is about 1.73%, and it has paid dividends for 10 years in our data.
Is American Healthcare REIT a good stock to buy?
We do not give buy or sell advice. American Healthcare REIT scores 1.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.